Samrat Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.09 Cr
- Company Age 32 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 49.00 Cr
- Satisfied Charges ₹ 17.55 Cr
- Revenue Growth 30.04%
- Profit Growth 25.88%
- Ebitda 26.79%
- Net Worth 21.94%
- Total Assets -1.63%
About Samrat Pharmachem
Samrat Pharmachem Limited (SPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 June 1992 and has a history of 32 years and eight months. Its registered office is in Vadodara, Gujarat, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530125.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.09 Cr.
The company currently has active open charges totaling ₹49.00 Cr. The company has closed loans amounting to ₹17.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Samrat Pharmachem Limited India are Nishant Kankaria as COMPANY SECRETARY and Rajesh Mehta as Cfo. Megha Jain, Sachin Kothary, Megh Mehta, and Four other members serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24230GJ1992PLC017820
- Company No.
017820
- Stock Symbol
BSE : 530125
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Jun 1992
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Samrat Pharmachem?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Mehta  | CFO | 01-Apr-2008 | Current |
| Lalit Mehta | Managing Director | 16-Jun-1992 | Current |
| Nishant Kankaria | Company Secretary | 22-May-2020 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Megh Mehta | Whole-Time Director | 01-Oct-2015 | Current |
| Megha Jain | Additional Director | 01-Aug-2024 | Current |
| Sachin Kothary | Additional Director | 23-Jul-2024 | Current |
| Renu Dharod | Director | 14-Feb-2015 | Current |
| Manishkumar Pipalia | Additional Director | 23-Jul-2024 | Current |
Financial Performance of Samrat Pharmachem.
Samrat Pharmachem Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 30.04% increase. The company also saw a substantial improvement in profitability, with a 25.88% increase in profit. The company's net worth Soared by an impressive increase of 21.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samrat Pharmachem?
In 2021, Samrat Pharmachem had a promoter holding of 49.30% and a public holding of 50.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹49.00 Cr
₹17.55 Cr
Charges Breakdown by Lending Institutions
- Others : 47.00 Cr
- Icici Bank Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2011 | Others | ₹2.00 Cr | Open |
| 21 Oct 2011 | Icici Bank Limited | ₹2.00 Cr | Open |
| 22 Dec 2007 | Others | ₹28.00 Cr | Open |
| 02 Nov 2005 | Others | ₹17.00 Cr | Open |
| 19 Oct 2011 | Hdfc Bank Limited | ₹3.20 Cr | Satisfied |
How Many Employees Work at Samrat Pharmachem?
Samrat Pharmachem has a workforce of 28 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samrat Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrat Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
